Focused Ultrasound for Essential Tremor: How It Works and Who Qualifies
Focused ultrasound for Essential Tremor is an incisionless, FDA-approved procedure that reduces tremor by targeting a small area of the thalamus. This page explains how it works, who qualifies, what to expect, the known risks, and non-surgical alternatives.
How Focused Ultrasound Treats Essential Tremor
Focused ultrasound uses MRI guidance to converge multiple ultrasound beams on the ventral intermediate, or VIM, nucleus of the thalamus. The concentrated heat ablates a precise area of tissue, disrupting the tremor circuit responsible for involuntary hand shaking. There is no incision and no radiation. Patients remain awake during the roughly two-hour outpatient procedure and are discharged the same day. FDA-approved in 2016, focused ultrasound surpassed deep brain stimulation in 2021 as the most common interventional procedure for Essential Tremor in the United States.
Who Is a Candidate for Focused Ultrasound?
Candidacy requires a confirmed Essential Tremor diagnosis that has not responded adequately to medication, and is determined through neurology evaluation, often supported by a CT scan of the skull. Patients must be able to undergo MRI, so pacemakers and certain metal implants are contraindicated. Skull bone density ratios below a clinical threshold can prevent adequate energy delivery to the target. Eligibility is generally limited to patients aged 22 and older. Bilateral tremor requires staged procedures with a minimum waiting period between sides.
What to Expect During and After the Procedure
The procedure is performed inside an MRI scanner while the patient is awake, allowing real-time testing of tremor response during ablation. Many patients see immediate improvement, confirmed before the procedure ends. Monitoring lasts about one hour before same-day discharge, with a follow-up commonly scheduled at one month. Many patients reduce or eliminate tremor medications after treatment. Five-year clinical data show roughly 73% improvement in tremor maintained at the five-year mark. Common side effects include temporary changes in balance or sensation; permanent effects are uncommon but possible.
How Focused Ultrasound Compares to Deep Brain Stimulation
When comparing Essential Tremor surgery options, deep brain stimulation requires an incision and implantation of an electrode and neurostimulator, while focused ultrasound creates a permanent thalamic lesion without implants. DBS is adjustable and reversible; focused ultrasound is not. DBS can treat both sides in one surgical episode; focused ultrasound requires staged sessions. Both show comparable tremor reduction in clinical studies, with DBS achieving more than 60% reduction and focused ultrasound roughly 73% at five years. DBS is often preferred for younger or bilateral cases.
Risks, Side Effects, and Limitations of Focused Ultrasound
Most side effects of this Essential Tremor surgery, including mild balance or sensory changes, are temporary and resolve within weeks. A minority of patients have persistent gait or sensory disturbances, as reported in the 2016 randomized trial in the New England Journal of Medicine by Elias and colleagues. The thalamic lesion is permanent and cannot be reversed. Skull bone characteristics prevent adequate treatment in some patients. The procedure is performed on one side per session. It is not a cure; insurance coverage varies.
When Focused Ultrasound Is Not the Right Option
Some patients are not candidates for focused ultrasound due to pacemakers, low skull density ratios, or the need for immediate bilateral relief. Others prefer to avoid interventional procedures or want to delay surgery. For these patients, medication management can continue under a neurologist's care, and wearable tremor stabilizers offer an immediately available, non-invasive option that requires no surgery or programming visits. The Steadi-3 is battery-free and designed for daily activities. Using it does not prevent patients from pursuing focused ultrasound at a later stage.
The Role of Wearable Devices in Essential Tremor Management
Essential Tremor management is best understood as a spectrum, ranging from medication to wearable assistive devices to interventional procedures such as focused ultrasound and deep brain stimulation. Wearable stabilizers can complement medication and help bridge the gap in daily life before or after a procedure. The Steadi-3 is an FDA-registered Class I medical device that uses patented passive magnetic damping and requires no batteries or charging. It is designed for tasks such as eating, writing, and drinking, and qualifies for FSA and HSA reimbursement. Discuss integration with your neurologist.
Frequently Asked Questions
Is focused ultrasound a cure for Essential Tremor?
No. Focused ultrasound is not a cure for Essential Tremor, and there is currently no known cure for the condition. The procedure reduces, or in some cases resolves, tremor symptoms by creating a targeted lesion in the thalamus, but the underlying condition remains. Some patients experience tremor recurrence or progression over time. Management, not cure, is the goal of all current treatment options, including medication, deep brain stimulation, focused ultrasound, and wearable assistive devices. Consulting a movement disorder neurologist is recommended.
Who is not a candidate for focused ultrasound?
Several factors can disqualify patients from focused ultrasound. Individuals with pacemakers, certain metal implants, kidney disease, or an inability to undergo an MRI are not eligible. Skull bone density ratios below the required threshold can prevent adequate energy delivery to the target brain area. Patients under the age of 22 are not currently approved candidates. A full neurological evaluation is required to confirm eligibility. Patients who do not qualify may benefit from alternative management strategies, including medication adjustments and wearable assistive devices.
How long does tremor relief last after focused ultrasound?
Clinical data show that focused ultrasound provides durable tremor reduction for most patients. A five-year follow-up study reported approximately 73% improvement in tremor, maintained at the five-year mark, consistent with earlier outcomes. Results vary between individuals, and some patients experience a gradual return of tremor over time. The thalamic lesion created by the procedure is permanent, so a second unilateral procedure is not typically performed on the same side. Patients should discuss long-term expectations and follow up with their treating neurologist.
What is the difference between focused ultrasound and deep-brain stimulation for Essential Tremor?
Both focused ultrasound and deep-brain stimulation target the thalamus to reduce tremor. Deep brain stimulation requires surgical implantation of electrodes and a neurostimulator, while focused ultrasound creates a permanent lesion without incisions or implants. DBS is reversible and adjustable; focused ultrasound is permanent and cannot be modified afterward. DBS can address both sides of the body in one surgical episode; focused ultrasound requires staged sessions. Both options produce comparable tremor reduction outcomes. A movement disorder neurologist can help identify the right approach.
Are there non-surgical options for Essential Tremor if I cannot have focused ultrasound?
Yes. Patients who do not qualify for focused ultrasound have several management options. Medications such as propranolol and primidone remain a first-line treatment for many patients. For a non-invasive, readily available option, FDA-registered wearable assistive devices, such as the Steadi-3 tremor glove, can reduce hand tremor during daily activities. The Steadi-3 uses patented passivYes. Patients who do not qualify for focused ultrasound have several management options. Medications such as propranolol and primidone remain a first-line treatment for many patients. For a non-invasive, readily available option, FDA-registered wearable assistive devices, such as the Steadi-3 tremor glove, can reduce hand tremor during daily activities. The Steadi-3 uses patented passive magnetic stabilization, requires no batteries or programming, and is supported by a placebo-controlled clinical study showing tremor reduction in 84% of users. Consult a neurologist and occupational therapist.
e magnetic stabilization, requires no batteries or programming, and is supported by a placebo-controlled clinical study showing tremor reduction in 84% of users. Consult a neurologist and occupational therapist.